Products
No. |
Product Name |
CAS No. |
391 |
6,11-Dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid |
55453-87-7 |
392 |
Azelaic acid |
123-99-9 |
393 |
Clemastine fumarate |
14976-57-9 |
394 |
Propantheline Bromide |
50-34-0 |
395 |
1-benzylpiperazin-2-one |
59702-21-5 |
396 |
Azelastine hydrochloride |
153408-27-6 |
397 |
Clindamycin HCl |
21462-39-5 |
398 |
Proparacaine hydrochloride |
5875-06-9 |
399 |
2-Oxo-1-phenyl-3-oxabicyclo[3.1.0]hexane |
63106-93-4 |
400 |
Azelnidipine |
123524-52-7 |
401 |
Clindamycin phosphate |
24729-96-2 |
402 |
Propiverine Hydrochloride |
54556-98-8 |
403 |
(3aR,4S,5R,6aS)-(-)-(tert-Butyldimethylsilyloxymethyl)hexahydro-5- (tetrahydro-2H-pyran-2-yloxy)-2H-cyclopenta[b]furan-2-one |
65025-95-8 |
404 |
Azithromycin Dihydrate |
117772-70-0 |
405 |
Clioquinol |
130-26-7 |
406 |
Propranolol Hcl |
3506-09-0 |
407 |
(1R,2R)-1,2-Cyclohexanedimethanol |
65376-05-8 |
408 |
Azithromycin |
83905-01-5 |
409 |
Clioquinol |
25122-46-7 |
410 |
Prostacyclin sodium salt |
61849-14-7 |
411 |
5-ethylindole |
68742-28-9 |
412 |
AZLOCILLIN |
37091-66-0 |
413 |
Clomipramine hydrochloride |
17321-77-6 |
414 |
Prostaglandin |
363-24-6 |
415 |
4-dibutylaminopyridine |
69008-71-5 |
416 |
AZTREONAM |
78110-38-0 |
417 |
Clopidogrel Bisulfate |
135046-48-9 |
418 |
cis-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-1-phenylcyclopropane- carboxylic acid |
69160-56-1 |
419 |
Clopidogrel bisulphate |
120202-66-6;135046-48-9 |
420 |
Prulifloxacin |
123447-62-1;123447-63-2 |
421 |
Ethyl 5-nitrobenzofuran-2-carboxylate |
69604-00-8 |
422 |
Cloprostenol |
55028-72-3;62561-03-9 |
423 |
Pumosetrag hydrochloride |
194093-42-0 |
424 |
2,3-Dihydrobenzofuranyl-5-acetic acid |
69999-16-2 |
425 |
Clorsulon |
60200-06-8 |
426 |
Pyrantel Pamoate |
22204-24-6 |
427 |
1-aminoindane hydrochloride |
70146-15-5 |
428 |
Cloxacillin Sodium Steril |
7081-44-9 |
429 |
Pyribencarb |
799247-52-2 |
430 |
3,5-DibroMopyridine-4-carboxaldehyde |
70201-42-2 |
.Remark: products patented are for R&D only and are permitted under 35 USC 271(e).
.Patent products cannot be offered to the countries where patent law is in force.
Final responsibility lies with the buyer exclusively.